Crucial role for endoplasmic reticulum stress during megakaryocyte maturation

Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2750-8. doi: 10.1161/ATVBAHA.113.302184. Epub 2013 Oct 10.

Abstract

Objective: Apoptotic-like phase is an essential step for the platelet formation from megakaryocytes. How controlled is this signaling pathway remained poorly understood. The aim of this study was to determine whether endoplasmic reticulum (ER) stress-induced apoptosis occurs during thrombopoiesis.

Approach and results: Investigation of ER stress and maturation markers in different models of human thrombopoiesis (CHRF, DAMI, MEG-01 cell lines, and hematopoietic stem cells: CD34(+)) as well as in immature pathological platelets clearly indicated that ER stress occurs transiently during thrombopoiesis. Direct ER stress induction by tunicamycin, an inhibitor of N-glycosylation, or by sarco/endoplasmic reticulum Ca(2+) ATPase type 3b overexpression, which interferes with reticular calcium, leads to some degree of maturation in megakaryocytic cell lines. On the contrary, exposure to salubrinal, a phosphatase inhibitor that prevents eukaryotic translation initiation factor 2α-P dephosphorylation and inhibits ER stress-induced apoptosis, decreased both expression of maturation markers in MEG-01 and CD34(+) cells as well as numbers of mature megakaryocytes and proplatelet formation in cultured CD34(+) cells.

Conclusions: Taken as a whole, our research suggests that transient ER stress activation triggers the apoptotic-like phase of the thrombopoiesis process.

Keywords: apoptosis; endoplasmic reticulum stress; platelet; thrombopoiesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD34 / metabolism
  • Apoptosis
  • Biomarkers / metabolism
  • Cell Line
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / metabolism*
  • Endoplasmic Reticulum / pathology
  • Endoplasmic Reticulum Stress* / drug effects
  • Eukaryotic Initiation Factor-2 / metabolism
  • Hematopoietic Stem Cells / drug effects
  • Hematopoietic Stem Cells / metabolism*
  • Hematopoietic Stem Cells / pathology
  • Humans
  • Megakaryocytes / drug effects
  • Megakaryocytes / metabolism*
  • Megakaryocytes / pathology
  • Phosphorylation
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / genetics
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism
  • Thrombopoiesis* / drug effects
  • Time Factors
  • Transfection

Substances

  • Antigens, CD34
  • Biomarkers
  • Eukaryotic Initiation Factor-2
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • ATP2A3 protein, human